CTCFL and chronic myelogenous leukemia, BCR-ABL1 positive: Despite the progress in our understanding of BORIS as a broad spectrum transcriptional regulator, it still remains unknown what pathways result in the differentiation of these CML cells upon KO of the BORIS gene.